[Therapeutic effect of capsule xinganbao on schistosomal hepatocirrhosis]

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011 Jun;23(3):284, 291.
[Article in Chinese]


A total of 118 patients with schistosomal hepatocirrhosis were divided into an experiment group (62 cases) and a control group (56 cases), and the former received capsule Xinganbao and the latter received conventional medicine for 6 months. The reductions of serum HA, LN and PCIII were more notable in the experiment group than in the control group (P < 0.05). The clinical symptoms, physical signs, and liver function improved in both groups, and there were no significant differences between two groups. In conclusions, capsule Xinganbao has a good effect on hepatic fibrosis.

Publication types

  • English Abstract
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Capsules
  • Drugs, Chinese Herbal / administration & dosage*
  • Female
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / drug therapy*
  • Male
  • Middle Aged
  • Phytotherapy
  • Schistosomiasis / complications
  • Schistosomiasis / drug therapy*
  • Treatment Outcome


  • Capsules
  • Drugs, Chinese Herbal